Radiotherapy utilization in developing countries: An IAEA study

Background: The planning of national radiotherapy (RT) services requires a thorough knowledge of the country’s cancer epidemiology profile, the radiotherapy utilization (RTU) rates and a future projection of these data. Previous studies have established RTU rates in high-income countries. Methods: Optimal RTU (oRTU) rates were determined for nine middle-income countries, following the epidemiological evidence-based method. The actual RTU (aRTU) rates were calculated dividing the total number of new notifiable cancer patients treated with radiotherapy in 2012 by the total number of cancer patients diagnosed in the same year in each country. An analysis of the characteristics of patients and treatments in a series of 300 consecutive radiotherapy patients shed light on the particular patient and treatments profile in the participating countries. Results: The median oRTU rate for the group of nine countries was 52% (47–56%). The median aRTU rate for the nine countries was 28% (9–46%). These results show that the real proportion of cancer patients receiving RT is lower than the optimal RTU with a rate difference between 10–42.7%. The median percent-unmet need was 47% (18–82.3%). Conclusions: The optimal RTU rate in middle-income countries did not differ significantly from that previously found in high-income countries. The actual RTU rates were consistently lower than the optimal, in particular in countries with limited resources and a large population. Crown Copyright 2018 Published by Elsevier B.V. All rights reserved. Radiotherapy and Oncology 128 (2018) 400–405The International Atomic Energy Agency, Vienna, Austria funded all meetings of national country coordinators, data collection and processing for this project. Supplementary data associated with this article can be found, in the online version, at https://doi.org/10.1016/j.radonc.2018.05. 014